DVAX Dynavax Technologies Corp

Dynavax to Present at the Jefferies Global Healthcare Conference

BERKELEY, CA--(Marketwired - Jun 2, 2014) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the Jefferies Global Healthcare Conference in New York on Thursday, June 5, 2014 at 2:30 p.m. Eastern Time (11:30 a.m. Pacific Time).

Michael Ostrach, Chief Business and Principal Financial Officer of Dynavax, will provide a company overview. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at http://investors.dynavax.com/newsevents.cfm.

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax's lead product candidate is HEPLISAV-B, a Phase 3 investigational adult hepatitis B vaccine. For more information visit www.dynavax.com.

Contact: Michael Ostrach Chief Business and Principal Financial Officer 510-665-7257 Email Contact